Funding for this research was provided by:
National Heart, Lung, and Blood Institute (5R01HL130192)
Received: 17 March 2020
Accepted: 3 April 2020
First Online: 21 April 2020
Ethics approval and consent to participate
: The trial was approved by the institutional review boards at the University of California San Francisco (approval number: 17-21505), Makerere University College of Health Sciences (HDREC 595), and the Uganda National Council for Science and Technology (HS 2437). It is registered with the US National Institutes of Health’s ExternalRef removed (identifier: NCT03044158) and the Pan African Clinical Trials Registry (identifier: PACTR201610001763265) as a phase 4 clinical trial.
: Not applicable
: The authors declare no competing interests.